Related Experiment Video
Updated: Jul 19, 2025

Development of New Therapeutic Applications Using Microfluidics
Published on: October 1, 2007
Drugs Are Not Microchips: Whither Industrial Policy In The Life Sciences?
J Stephen Morrison1, Michaela Simoneau2
1J. Stephen Morrison (smorrison@csis.org), Center for Strategic and International Studies, Washington, D.C.
Abstract:
Events such as Russia's invasion of Ukraine in February 2022 have heightened global awareness of the potential for sudden market upheaval and the need for proactive measures to protect supply chains, including in the life sciences. But advancing an industrial policy on drugs requires several unique conditions-including a continued sense of acute threat among the US and its allies, ample public-sector funding, real-time data, industry buy-in, and bipartisan support in Congress-that are currently not present in the US.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
The Central Dogma
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
Global Regulatory Systems
Drug Regulation

